IL10 and ulcerative colitis: Thus, our data show a protective role of CLP in the model of ulcerative colitis, since the treatment of the animals with this alkaloid negatively regulated the levels of Th1 and Th17 cytokines and increased the production of IL-10, known as a cytokine with anti-inflammatory activity [52,53].